PERSONALIZE MY TREATMENT (PMT) Trademark

Trademark Overview

On Wednesday, September 30, 2020, a trademark application was filed for PERSONALIZE MY TREATMENT (PMT) with the United States Patent and Trademark Office. The USPTO has given the PERSONALIZE MY TREATMENT (PMT) trademark a serial number of 90226501. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Thursday, March 7, 2024. This trademark is owned by Exactis Innovation. The PERSONALIZE MY TREATMENT (PMT) trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Biobank services in the nature of providing access to a bank of human blood, biological and tissue samples for cancer patients

Platform as a service (PAAS) featuring computer software platforms in the field of oncology, for matching cancer patients to biology driven clinical trials based on the molecular profile of their tumour; providing an on-line computer database in the field of medical and scientific research information in the field of clinical trials, featuring medical and scientific research information pertaining to a patient's molecular, clinical, epidemiological data and research findings for use in silico trial design, for matching cancer patients to clinical trials and for studying health econometrics; providing an on-line computer database in the field of medical and scientific research as it pertains to cancer treatment, diagnosis and molecular profiling
personalize my treatment (pmt)

General Information

Serial Number90226501
Word MarkPERSONALIZE MY TREATMENT (PMT)
Filing DateWednesday, September 30, 2020
Status653 - SUSPENSION LETTER - MAILED
Status DateThursday, March 7, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesBiobank services in the nature of providing access to a bank of human blood, biological and tissue samples for cancer patients
Goods and ServicesPlatform as a service (PAAS) featuring computer software platforms in the field of oncology, for matching cancer patients to biology driven clinical trials based on the molecular profile of their tumour; providing an on-line computer database in the field of medical and scientific research information in the field of clinical trials, featuring medical and scientific research information pertaining to a patient's molecular, clinical, epidemiological data and research findings for use in silico trial design, for matching cancer patients to clinical trials and for studying health econometrics; providing an on-line computer database in the field of medical and scientific research as it pertains to cancer treatment, diagnosis and molecular profiling

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, March 12, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, November 14, 2020
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameExactis Innovation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMontréal, Québec H3T1Y6
CA

Trademark Events

Event DateEvent Description
Thursday, March 7, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, March 7, 2024LETTER OF SUSPENSION E-MAILED
Thursday, March 7, 2024SUSPENSION LETTER WRITTEN
Monday, January 22, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 22, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 19, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, November 7, 2023NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, November 7, 2023INQUIRY TO SUSPENSION E-MAILED
Tuesday, November 7, 2023SUSPENSION INQUIRY WRITTEN
Friday, April 21, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, April 21, 2023LETTER OF SUSPENSION E-MAILED
Friday, April 21, 2023SUSPENSION LETTER WRITTEN
Thursday, April 20, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 20, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 20, 2023ASSIGNED TO LIE
Wednesday, April 12, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, January 27, 2023NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, January 27, 2023INQUIRY TO SUSPENSION E-MAILED
Friday, January 27, 2023SUSPENSION INQUIRY WRITTEN
Friday, July 15, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, July 15, 2022LETTER OF SUSPENSION E-MAILED
Friday, July 15, 2022SUSPENSION LETTER WRITTEN
Thursday, June 2, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 2, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, May 28, 2022ASSIGNED TO LIE
Wednesday, May 25, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sunday, November 28, 2021NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Sunday, November 28, 2021INQUIRY TO SUSPENSION E-MAILED
Sunday, November 28, 2021SUSPENSION INQUIRY WRITTEN
Wednesday, October 27, 2021SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, April 19, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, April 19, 2021LETTER OF SUSPENSION E-MAILED
Monday, April 19, 2021SUSPENSION LETTER WRITTEN
Friday, March 12, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 11, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 11, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 25, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 25, 2021NON-FINAL ACTION E-MAILED
Thursday, February 25, 2021NON-FINAL ACTION WRITTEN
Wednesday, February 24, 2021ASSIGNED TO EXAMINER
Saturday, November 14, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, October 3, 2020NEW APPLICATION ENTERED

Related Keywords

treatment personalize clinical field research cancer patients computer molecular scientific medical trials